ArticlePharmaceutical biology2022

Fraxinol attenuates LPS-induced acute lung injury by equilibrating ACE-Ang II-AT1R and ACE2-Ang (1-7)-Mas and inhibiting NLRP3.

Yan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.